FINANCIAL RESULTS & EVENTS Investor presentations Facebook Twitter LinkedIn 2021 December 1, 2021 Vaccines Day ACCESS ALL INFORMATION February 5, 2021 Capital Markets Day 2021 ACCESS ALL INFORMATION 2020 August 17, 2020 IR call on the acquisition of Principia Biopharma Inc. ACCESS ALL INFORMATION July 30, 2020 R&D DAYS 5/5: Nirsevimab R&D investor event ACCESS ALL INFORMATION June 23, 2020 R&D DAYS 4/5: Virtual R&D Day investor event ACCESS ALL INFORMATION June 11, 2020 R&D DAYS 3/5: Dupixent® R&D investor event ACCESS ALL INFORMATION June 2, 2020 R&D DAYS 2/5: Oncology strategy and ASCO R&D investor event ACCESS ALL INFORMATION April 23, 2020 R&D DAYS 1/5: BTKi ('168) R&D investor event ACCESS ALL INFORMATION March 27, 2020 IR call: Sanofi expands collaboration with Translate Bio to develop mRNA COVID-19 vaccine ACCESS ALL INFORMATION February 24, 2020 IR call: Sanofi to create new industry leading European company to provide APIs ACCESS ALL INFORMATION 2019 December 10, 2019 Capital Markets Day ACCESS ALL INFORMATION 2018 March 10, 2018 IR conference call on Odyssey Outcomes ACCESS ALL INFORMATION January 29, 2018 IR call on the acquisition of Ablynx ACCESS ALL INFORMATION January 22, 2018 IR call on the acquisition of Bioverativ Inc. ACCESS ALL INFORMATION 2017 December 13, 2017 Sustaining Innovation Analyst Day ACCESS ALL INFORMATION March 28, 2017 Dupixent® FDA approval call ACCESS ALL INFORMATION 2016 October 1, 2016 IR thematic call on dupilumab ACCESS ALL INFORMATION June 27, 2016 Sanofi organized a conference call following the signing of contracts with Boehringer Ingelheim. ACCESS ALL INFORMATION 2015 November 9, 2015 IR thematic call on sarilumab Sanofi and Regeneron hosted a conference call on sarilumab. ACCESS ALL INFORMATION November 6, 2015 Meet Sanofi Management Sanofi organized a Meet Management Seminar focusing on its strategic roadmap 2020. ACCESS ALL INFORMATION July 24, 2015 IR thematic call on Praluent® FDA approval Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S. ACCESS ALL INFORMATION June 9, 2015 IR thematic call on Diabetes Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S. ACCESS ALL INFORMATION 2014 November 20, 2014 IR thematic seminar on New Medicines Sanofi hosted an IR Thematic Seminar on New Medicines. ACCESS ALL INFORMATION October 29, 2014 IR thematic call with Serge Weinberg Sanofi held a conference call with Serge Weinberg for the financial community. ACCESS ALL INFORMATION September 2, 2014 IR thematic call on alirocumab Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the European Society of Cardiology Congress in Barcelona. ACCESS ALL INFORMATION June 16, 2014 IR thematic call on Diabetes Sanofi hosted a Thematic Conference Call on Diabetes in connection with the American Diabetes Association's Scientific Sessions. ACCESS ALL INFORMATION March 31, 2014 IR thematic call on alirocumab Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the American College of Cardiology Annual Meeting. ACCESS ALL INFORMATION Follow us Sanofi on Twitter Sanofi TV on YouTube Sanofi On LinkedIn Sanofi on Instagram Sanofi RSS feeds Contact Legal notice Privacy & Data Protection Cookies policy Corporate code of ethics Our publications Sitemap Our websites Accessibility: partial compliance © Sanofi 2004-2021 - All rights reserved Your privacy is important to us By clicking “Accept All” , you agree to the storing of cookies on your device to enhance site navigation, measure site performance and show you personalized advertising. You can manage individual cookies preferences or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third-parties intervening on our website, please consult the Cookies Policy, available in the site footer. Cookies settings Reject all Accept all